aod9604 fat loss clinical trials results versus GLP-1 safety comparison Chapter 16: Beyond the Horizon

Unlike salbutamol, there are no exceptions for the use of levosalbutamol based on any therapeutic dose

Biomolecules 10 , 604 (2020)

It is the only peptide in this guide that is FDA-approved with a primary indication for reducing abdominal fat, placing it in a unique regulatory position among the best peptides for weight loss targeting visceral adiposity

When to Adjust Dosing Increase dose if: After 4-6 weeks at current dose, no measurable body composition changes occur, youre tolerating current dose without side effects, youre below the upper clinical range (1 mg daily), and your physician approves escalation based on comprehensive assessment

Follow-Up and Monitoring We schedule follow-up appointments to track your body composition changes, assess progress, and adjust your protocol as needed

Over time, repeated clinic visits can easily mean thousands of dollars a month for those on a daily injection protocol